| Exchange | Price | % Move |
|---|---|---|
| CSE:EXM | ||
| FSE:A2PAW2 |
-
EXM is focused on the industrial extraction, purification and refining of individual cannabinoids to pharmaceutical-grade
Learn More -
Reliability, Quality, Trust, and Compliance
Learn More -
We are targeting the medical and legal 200bn USD global cannabis market estimated for 2028
Learn More
Medical grade ingredients
EXMceuticals (“EXM”) is a medical cannabis company that strongly believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with ambition and potential to become one of the world's suppliers of highest-grade cannabis ingredients. EXM is currently creating an industrial-scale, GMP, and Pharmaceutical Grade extraction and refining unit inside the European Union, near Lisbon Portugal. EXM has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients to the pharmaceutical, medicinal and wellness industry
Research Driven
Research-driven in cannabis extraction, distillation, purification and cannabinoid isolation with industry leading scientists
Innovation
Fully operational R&D laboratory in Portugal will now develop cannabis-based formulations for products and operate as a pilot-scale refinery for the transformation of cannabis-based ingredients.
Medical
Focused on providing the right ingredients to consumer goods infused products, capsules and oils for the medicinal and wellness industry. We control our cultivation, extraction, refining and manufacturing practices
Flexible Revenue Model
Our state-of-the-art testing lab is equipped to conduct all quality control testing for third parties. Processing Services to transform biomass or oil into high-grade extracts and white labelling services in the creation of custom extracts for specific product formulations.
Investor information
EXMceuticals Inc. Sets its Sights firmly on the estimated €200 Billion value of the combined European and US cannabis market in 2028 .
Our Portuguese extraction and refinery hub will process the raw materials from GMP certified suppliers in both Portugal and Internationally. Portugal will serve as the gateway to distribute pure ingredients across Europe and into North America & Asia.
Updates
Research and Development
EXMceuticals's fully operational R&D laboratory in Portugal will now develop cannabis-based formulations for products and operate as a pilot-scale refinery ...
EXMceuticals obtains its research and development
EXMceuticals Portugal has obtained the authorization for cannabis research and development from INFARMED, the Portuguese National Authority of Medicines and ...